|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$86,043,464 |
|
|
Indirect Value
|
$13,186,326,474 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,272,369,938 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
9
|
6
|
Stock
price went up :
|
0
|
6
|
Stock
price went down : |
9
|
0
|
|
|
|
Gain/Loss Ratio : |
-9.0
|
6.0
|
Percentage
Gain/Loss : |
-27.9%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 26 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2011-12-05 |
4 |
B |
$28.39 |
$15,593 |
I/I |
548 |
192,064 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-12-05 |
4 |
B |
$28.39 |
$582,072 |
I/I |
20,456 |
6,901,703 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-08 |
4 |
B |
$26.17 |
$139,904 |
I/I |
5,340 |
197,404 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-08 |
4 |
B |
$26.17 |
$5,294,564 |
I/I |
202,089 |
7,103,792 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-08 |
4 |
B |
$26.17 |
$868,267 |
I/I |
33,141 |
1,339,422 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-09 |
4 |
B |
$26.24 |
$1,473,628 |
I/I |
55,994 |
7,159,786 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-09 |
4 |
B |
$26.24 |
$233,174 |
I/I |
8,860 |
1,348,282 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-09 |
4 |
B |
$26.24 |
$38,897 |
I/I |
1,478 |
198,882 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-10 |
4 |
B |
$26.52 |
$4,249,931 |
I/I |
159,832 |
7,319,618 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-10 |
4 |
B |
$26.52 |
$653,635 |
I/I |
24,582 |
1,372,864 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-10 |
4 |
B |
$26.52 |
$112,343 |
I/I |
4,225 |
203,107 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-14 |
4 |
B |
$28.44 |
$1,586,898 |
I/I |
55,804 |
7,375,422 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-14 |
4 |
B |
$28.44 |
$41,945 |
I/I |
1,475 |
204,582 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-14 |
4 |
B |
$28.44 |
$208,756 |
I/I |
7,341 |
1,380,205 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-15 |
4 |
B |
$28.88 |
$927,680 |
I/I |
32,125 |
7,407,547 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-15 |
4 |
B |
$28.88 |
$24,517 |
I/I |
849 |
205,431 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-15 |
4 |
B |
$28.88 |
$113,892 |
I/I |
3,944 |
1,384,149 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-16 |
4 |
B |
$28.96 |
$5,499,497 |
I/I |
184,980 |
7,592,527 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-16 |
4 |
B |
$28.96 |
$145,350 |
I/I |
4,889 |
210,320 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-16 |
4 |
B |
$28.96 |
$651,092 |
I/I |
21,900 |
1,406,049 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-21 |
4 |
B |
$27.98 |
$1,312,368 |
I/I |
46,909 |
7,639,436 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-21 |
4 |
B |
$27.98 |
$145,955 |
I/I |
5,217 |
1,411,266 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-21 |
4 |
B |
$27.98 |
$34,635 |
I/I |
1,238 |
211,558 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-22 |
4 |
B |
$27.98 |
$17,852 |
I/I |
638 |
1,411,904 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-22 |
4 |
B |
$27.98 |
$4,057 |
I/I |
145 |
211,703 |
2.17 |
- |
|
1397 Records found
|
|
Page 26 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|